Contents of Cancer Biology & Medicine in 2022（Issue 7-12）
As a peer-reviewed open-access journal, Cancer Biology & Medicine (CBM) is published by China Anti-Cancer Association and Tianjin Medical University Cancer Institute & Hospital. It focuses on translational cancer research, dedicating to narrowing the gap between bench and bedside. CBM strictly adheres to guidelines of the International Committee of Medical Journal Editors (ICMJE), and Committee on Publication Ethics (COPE). The journal is now indexed in Science Citation Index Expanded (SCIE, IF=5.347, 5-year IF=6.624) and MEDLINE. All full texts are available in PubMed via http://www.ncbi.nlm.nih.gov/pmc/journals/2000/.
The contents of the 7th-12th issue are as followed. Welcome to submit your work to CBM, which is a trusty international platform, to disseminate your research and viewpoints.
Issue 7
Editorial
Rosiglitazone disrupts pancreatic ductal adenocarcinoma progression by activating the tumor suppressor ESE3/EHF
Hongquan Wang, Shuang Wu, Yan Wang and Bo Tang
Cancer Biology & Medicine July 2022, 19 (7) 945-947;
DOI: https://doi.org/10.20892/j.issn.2095-3941.2022.0299
Reviews
Eliciting pyroptosis to fuel cancer immunotherapy: mechanisms and strategies
Wuyin Wang, Lu Zhang and Zhijun Sun
Cancer Biology & Medicine July 2022, 19 (7) 948-964;
DOI: https://doi.org/10.20892/j.issn.2095-3941.2022.0049
Living biobank-based cancer organoids: prospects and challenges in cancer research
Haixin Li, Hongkun Liu and Kexin Chen
Cancer Biology & Medicine July 2022, 19 (7) 965-982;
DOI: https://doi.org/10.20892/j.issn.2095-3941.2021.0621
Original Articles
ANTP-SMACN7 fusion peptide alone induced high linear energy transfer irradiation radiosensitization in non-small cell lung cancer cell lines
Yi Xie, Bing Wang, Liqing Du, Yan Wang, Chang Xu, Hong Zhang, Kaixue Wen, Qiang Liu and Takanori Katsube
Cancer Biology & Medicine July 2022, 19 (7) 983-994;
DOI: https://doi.org/10.20892/j.issn.2095-3941.2020.0569
SY-1530, a highly selective BTK inhibitor, effectively treats B-cell malignancies by blocking B-cell activation
Liao Wang, Yinghui Sun, Xijie Liu, Hongjuan Li, Chang Lu, Ronghui Yang, Chuanzhen Yang and Binghui Li
Cancer Biology & Medicine July 2022, 19 (7) 995-1007;
DOI: https://doi.org/10.20892/j.issn.2095-3941.2020.0291
IL13Rα1 prevents a castration resistant phenotype of prostate cancer by targeting hexokinase 2 for ubiquitin-mediated degradation
Tingting Feng, Jing Wang, Kai Cheng, Qiqi Lu, Ru Zhao, Shiguan Wang, Qingyun Zhang, Luna Ge, Jihong Pan, Guanhua Song and Lin Wang
Cancer Biology & Medicine July 2022, 19 (7) 1008-1028;
DOI: https://doi.org/10.20892/j.issn.2095-3941.2020.0583
Identification of hub genes and their novel diagnostic and prognostic significance in pancreatic adenocarcinoma
Duo Zuo, Yongzi Chen, Xinwei Zhang, Zhuozhi Wang, Wenna Jiang, Fan Tang, Runfen Cheng, Yi Sun, Lu Sun, Li Ren and Rui Liu
Cancer Biology & Medicine July 2022, 19 (7) 1029-1046;
DOI: https://doi.org/10.20892/j.issn.2095-3941.2020.0516
Dual-targeted lung cancer therapy via inhalation delivery of UCNP-siRNA-AS1411 nanocages
Yu Han, Yuming Yang, Qiuyang Sun, Bin Li, Caixia Yue, Yanlei Liu, Jesús M. de la Fuente and Daxiang Cui
Cancer Biology & Medicine July 2022, 19 (7) 1047-1060;
DOI: https://doi.org/10.20892/j.issn.2095-3941.2020.0416
Bilirubin inhibits the anticancer activity of sorafenib by blocking MCL-1 degradation in hepatocellular carcinoma cells
Leyi Yao, Qian Zhao, Ding Yan, Ziying Lei, Yali Hao, Jinghong Chen, Qian Xue, Xiaofen Li, Qingtian Huang, Daolin Tang, Q. Ping Dou, Xin Chen and Jinbao Liu
Cancer Biology & Medicine July 2022, 19 (7) 1061-1077;
DOI: https://doi.org/10.20892/j.issn.2095-3941.2021.0598
Microwave ablation vs. surgical resection for treatment naïve hepatocellular carcinoma within the Milan criteria: a follow-up of at least 5 years
Jianping Dou, Zhigang Cheng, Zhiyu Han, Fangyi Liu, Zhen Wang, Xiaoling Yu, Jie Yu and Ping Liang
Cancer Biology & Medicine July 2022, 19 (7) 1078-1088;
DOI: https://doi.org/10.20892/j.issn.2095-3941.2020.0625
Fotemustine-based therapy in combination with rituximab as a first-line induction chemotherapy followed by WBRT for newly diagnosed primary central nervous system lymphoma: a prospective phase II trial
Jingjing Wu, Fenghua Gao, Wenhua Wang, Xudong Zhang, Meng Dong, Lei Zhang, Xin Li, Ling Li, Zhenchang Sun, Xinhua Wang, Xiaorui Fu, Linan Zhu, Mengjie Ding, Songtao Niu, Zhaoming Li, Yu Chang, Feifei Nan, Jiaqian Yan, Hui Yu, Xiaolong Wu, Zhiyuan Zhou, Jieming Zhang and Mingzhi Zhang
Cancer Biology & Medicine July 2022, 19 (7) 1089-1099;
DOI: https://doi.org/10.20892/j.issn.2095-3941.2021.0026
Feasibility of sentinel lymph node biopsy omission after integration of 18F-FDG dedicated lymph node PET in early breast cancer: a prospective phase II trial
Junjie Li, Jingyi Cheng, Guangyu Liu, Yifeng Hou, Genghong Di, Benglong Yang, Yizhou Jiang, Liang Huang, Feilin Qu, Sheng Chen, Yan Wang, Keda Yu and Zhimin Shao
Cancer Biology & Medicine July 2022, 19 (7) 1100-1108;
DOI: https://doi.org/10.20892/j.issn.2095-3941.2022.0085
Erratum
Erratum to DYRK1A suppression restrains Mcl-1 expression and sensitizes NSCLC cells to Bcl-2 inhibitors
Yangling Li, Dongmei Zhou, Shuang Xu, Mingjun Rao, Zuoyan Zhang, Linwen Wu, Chong Zhang and Nengming Lin
Cancer Biology & Medicine July 2022, 19 (7) 1109-1110;
DOI: https://doi.org/10.20892/j.issn.2095-3941.2022.0172
Issue 8
Perspective
Epigenetic reprogramming in small cell lung cancer
Jingyao Chen, Xiangyu Pan, Feifei Na, Xuelan Chen and Chong Chen
Cancer Biology & Medicine August 2022, 19 (8) 1111-1116;
DOI: https://doi.org/10.20892/j.issn.2095-3941.2022.0343
Editorial
Update on diffuse large B-cell lymphoma: highlights from the 2022 ASCO Annual Meeting
Minghan Qiu, Shan Wu, Xinrui Chen and Huaqing Wang
Cancer Biology & Medicine August 2022, 19 (8) 1117-1120;
DOI: https://doi.org/10.20892/j.issn.2095-3941.2022.0403
Review
Current cancer burden in China: epidemiology, etiology, and prevention
Maomao Cao, He Li, Dianqin Sun, Siyi He, Xinxin Yan, Fan Yang, Shaoli Zhang, Changfa Xia, Lin Lei, Ji Peng and Wanqing Chen
Cancer Biology & Medicine August 2022, 19 (8) 1121-1138;
DOI: https://doi.org/10.20892/j.issn.2095-3941.2022.0231
Original Articles
Alterations in DNA damage response and repair genes as potential biomarkers for immune checkpoint blockade in gastrointestinal cancer
Yujiao Wang, Xi Jiao, Shuang Li, Huan Chen, Xin Wei, Chang Liu, Jifang Gong, Xiaotian Zhang, Xicheng Wang, Zhi Peng, Changsong Qi, Zhenghang Wang, Yanni Wang, Na Zhuo, Jianling Zou, Henghui Zhang, Jian Li, Lin Shen and Zhihao Lu
Cancer Biology & Medicine August 2022, 19 (8) 1139-1149;
DOI: https://doi.org/10.20892/j.issn.2095-3941.2020.0708
BLM helicase inhibition synergizes with PARP inhibition to improve the radiosensitivity of olaparib resistant non-small cell lung cancer cells by inhibiting homologous recombination repair
Yangyang Kong, Chang Xu, Xiaohui Sun, Hao Sun, Xiaotong Zhao, Ningning He, Kaihua Ji, Qin Wang, Liqing Du, Jinhan Wang, Manman Zhang, Yang Liu, Yan Wang and Qiang Liu
Cancer Biology & Medicine August 2022, 19 (8) 1150-1171;
DOI: https://doi.org/10.20892/j.issn.2095-3941.2021.0178
The HDAC inhibitor GCJ-490A suppresses c-Met expression through IKKα and overcomes gefitinib resistance in non-small cell lung cancer
Ting He, Yinglei Gao, Yanfen Fang, Yangming Zhang, Shuwei Zhang, Fajun Nan, Jian Ding and Yi Chen
Cancer Biology & Medicine August 2022, 19 (8) 1172-1192;
DOI: https://doi.org/10.20892/j.issn.2095-3941.2021.0130
Loss of NEIL3 activates radiotherapy resistance in the progression of prostate cancer
Qiong Wang, Zean Li, Jin Yang, Shirong Peng, Qianghua Zhou, Kai Yao, Wenli Cai, Zhongqiu Xie, Fujun Qin, Hui Li, Xu Chen, Kaiwen Li and Hai Huang
Cancer Biology & Medicine August 2022, 19 (8) 1193-1210;
DOI: https://doi.org/10.20892/j.issn.2095-3941.2020.0550
PYK2 mediates the BRAF inhibitor (vermurafenib)-induced invadopodia formation and metastasis in melanomas
Junling Shen, Jilong Yang, Lei Sang, Rui Sun, Weiyu Bai, Chao Wang, Yan Sun and Jianwei Sun
Cancer Biology & Medicine August 2022, 19 (8) 1211-1223;
DOI: https://doi.org/10.20892/j.issn.2095-3941.2020.0294
Frequent low dose alcohol intake increases gastric cancer risk: the Health Examinees-Gem (HEXA-G) study
Hwi-Won Lee, Dan Huang, Woo-Kyoung Shin, Katherine de la Torre, Minkyo Song, Aesun Shin, Jong-Koo Lee and Daehee Kang
Cancer Biology & Medicine August 2022, 19 (8) 1224-1234;
DOI: https://doi.org/10.20892/j.issn.2095-3941.2021.0642
Lynch syndrome pre-screening and comprehensive characterization in a multi-center large cohort of Chinese patients with colorectal cancer
Yan Li, Lihong Fan, Jianming Zheng, Xiu Nie, Yu Sun, Qin Feng, Shenyi Lian, Wenqi Bai, Weijing Cai, Yanan Yang, Bo Su, Yanfeng Xi and Dongmei Lin
Cancer Biology & Medicine August 2022, 19 (8) 1235-1248;
DOI: https://doi.org/10.20892/j.issn.2095-3941.2021.0585
Peripheral blood indices to predict PFS/OS with anlotinib as a subsequent treatment in advanced small-cell lung cancer
Cuicui Zhang, Jing Wang, Xinyue Wang, Zhaoting Meng, Ying Cheng and Kai Li
Cancer Biology & Medicine August 2022, 19 (8) 1249-1258;
DOI: https://doi.org/10.20892/j.issn.2095-3941.2020.0727
Effects of Helicobacter pylori eradication on the profiles of blood metabolites and their associations with the progression of gastric lesions: a prospective follow-up study
Wenhui Wu, Zongchao Liu, Zhexuan Li, Weidong Liu, Lanfu Zhang, Yang Zhang, Tong Zhou, Weicheng You, Kaifeng Pan and Wenqing Li
Cancer Biology & Medicine August 2022, 19 (8) 1259-1273;
DOI: https://doi.org/10.20892/j.issn.2095-3941.2022.0255
Prospective study of the effect of ERAS on postoperative recovery and complications in patients with gastric cancer
Ye Tian, Qiang Li and Yuan Pan
Cancer Biology & Medicine August 2022, 19 (8) 1274-1281;
DOI: https://doi.org/10.20892/j.issn.2095-3941.2021.0108
Issue 9
Editorial
Reflections on the withdrawal of medical articles and the development of writing and publishing standards
Lidong Wang and Zhihua Liu
Cancer Biology & Medicine September 2022, 19 (9) 1283-1289;
DOI: https://doi.org/10.20892/j.issn.2095-3941.2022.0437
Review
Bacterial outer membrane vesicle-based cancer nanovaccines
Xiaoyu Gao, Qingqing Feng, Jing Wang and Xiao Zhao
Cancer Biology & Medicine September 2022, 19 (9) 1290-1300;
DOI: https://doi.org/10.20892/j.issn.2095-3941.2022.0452
Original Articles
Exosomal miR-155 from gastric cancer induces cancer-associated cachexia by suppressing adipogenesis and promoting brown adipose differentiation via C/EPBβ
Ying Liu, Meng Wang, Ting Deng, Rui Liu, Tao Ning, Ming Bai, Guoguang Ying, Haiyang Zhang and Yi Ba
Cancer Biology & Medicine September 2022, 19 (9) 1301-1314;
DOI: https://doi.org/10.20892/j.issn.2095-3941.2021.0220
Glycolytic potential enhanced by blockade of pyruvate influx into mitochondria sensitizes prostate cancer to detection and radiotherapy
Huan Xu, Junyi Chen, Zhi Cao, Xi Chen, Caihong Huang, Jin Ji, Yalong Xu, Junfeng Jiang, Yue Wang, Guowang Xu, Lina Zhou, Jingyi He, Xuedong Wei, Jason Boyang Wu, Zhong Wang, Shancheng Ren and Fubo Wang
Cancer Biology & Medicine September 2022, 19 (9) 1315-1333;
DOI: https://doi.org/10.20892/j.issn.2095-3941.2021.0638
Panoramic comparison between NK cells in healthy and cancerous liver through single-cell RNA sequencing
Huan Liu, Ronghua Zhao, Rongrong Qin, Haoyu Sun, Qiang Huang, Lianxin Liu, Zhigang Tian, Björn Nashan, Cheng Sun and Rui Sun
Cancer Biology & Medicine September 2022, 19 (9) 1334-1351;
DOI: https://doi.org/10.20892/j.issn.2095-3941.2022.0050
Hub genes associated with immune cell infiltration in breast cancer, identified through bioinformatic analyses of multiple datasets
Huanyu Zhao, Ruoyu Dang, Yipan Zhu, Baijian Qu, Yasra Sayyed, Ying Wen, Xicheng Liu, Jianping Lin and Luyuan Li
Cancer Biology & Medicine September 2022, 19 (9) 1352-1374;
DOI: https://doi.org/10.20892/j.issn.2095-3941.2021.0586
Development and evaluation of the screening performance of a low-cost high-risk screening strategy for breast cancer
Yubei Huang, Huan Wang, Zhangyan Lyu, Hongji Dai, Peifang Liu, Ying Zhu, Fengju Song and Kexin Chen
Cancer Biology & Medicine September 2022, 19 (9) 1375-1384;
DOI: https://doi.org/10.20892/j.issn.2095-3941.2020.0758
A causal variant rs3769823 in 2q33.1 involved in apoptosis pathway leading to a decreased risk of non-small cell lung cancer
Xu Zhang, Na Qin, Jingyi Fan, Chang Zhang, Qi Sun, Yayun Gu, Meng Zhu, Erbao Zhang, Juncheng Dai, Guangfu Jin, Hongxia Ma, Zhibin Hu and Hongbing Shen
Cancer Biology & Medicine September 2022, 19 (9) 1385-1396;
DOI: https://doi.org/10.20892/j.issn.2095-3941.2022.0068
Detection and surveillance of circulating tumor cells in osteosarcoma for predicting therapy response and prognosis
Haoran Mu, Dongqing Zuo, Jie Chen, Zhigang Liu, Zhuo Wang, Liu Yang, Qihui Shi and Yingqi Hua
Cancer Biology & Medicine September 2022, 19 (9) 1397-1409;
DOI: https://doi.org/10.20892/j.issn.2095-3941.2022.0279
Comparison of outcomes between immediate implant-based and autologous reconstruction: 15-year, single-center experience in a propensity score-matched Chinese cohort
Shanshan He, Bowen Ding, Gang Li, Yubei Huang, Chunyong Han, Jingyan Sun, Qingfeng Huang, Jing Liu, Zhuming Yin, Shu Wang and Jian Yin
Cancer Biology & Medicine September 2022, 19 (9) 1410-1421;
DOI: https://doi.org/10.20892/j.issn.2095-3941.2021.0368
Issue 10
Editorial
Role of the tumor microenvironment in shaping IDH-wildtype glioma plasticity, and potential therapeutic strategies
Lingxiang Wu, Ruichao Chai, Zheng Zhao, Qianghu Wang and Tao Jiang
Cancer Biology & Medicine October 2022, 19 (10) 1423-1427;
DOI: https://doi.org/10.20892/j.issn.2095-3941.2022.0363
Reviews
Targeting PP2A for cancer therapeutic modulation
Halle Ronk, Jared S. Rosenblum, Timothy Kung and Zhengping Zhuang
Cancer Biology & Medicine October 2022, 19 (10) 1428-1439;
DOI: https://doi.org/10.20892/j.issn.2095-3941.2022.0330
Epidemiological characteristics and genetic alterations in adult diffuse glioma in East Asian populations
Zongchao Mo, Junyi Xin, Ruichao Chai, Peter Y.M. Woo, Danny T.M. Chan and Jiguang Wang
Cancer Biology & Medicine October 2022, 19 (10) 1440-1459;
DOI: https://doi.org/10.20892/j.issn.2095-3941.2022.0418
Original Articles
Clinical management and survival outcomes of patients with different molecular subtypes of diffuse gliomas in China (2011–2017): a multicenter retrospective study from CGGA
Kenan Zhang, Xing Liu, Guanzhang Li, Xin Chang, Shouwei Li, Jing Chen, Zheng Zhao, Jiguang Wang, Tao Jiang and Ruichao Chai
Cancer Biology & Medicine October 2022, 19 (10) 1460-1476;
DOI: https://doi.org/10.20892/j.issn.2095-3941.2022.0469
Radiotherapy delays malignant transformation and prolongs survival in patients with IDH-mutant gliomas
Yanwei Liu, Huiyuan Chen, Guanzhang Li, Jing Zhang, Kun Yao, Chenxing Wu, Shouwei Li and Xiaoguang Qiu
Cancer Biology & Medicine October 2022, 19 (10) 1477-1486;
DOI: https://doi.org/10.20892/j.issn.2095-3941.2022.0472
Other Papers
Editorial
Insights into the transition of ductal carcinoma in situ to invasive ductal carcinoma: morphology, molecular portraits, and the tumor microenvironment
Weiling Chen, Guimei Wang and Guojun Zhang
Cancer Biology & Medicine October 2022, 19 (10) 1487-1495;
DOI: https://doi.org/10.20892/j.issn.2095-3941.2022.0440
Perspective
Therapeutic perspectives for adult soft tissue sarcoma—updates from the 2022 ASCO annual meeting
Jilong Yang, Yu Xu, Yong Chen, Tao Li, Xiaowei Zhang, Tu Hu, Ruwei Xing and Yun Yang
Cancer Biology & Medicine October 2022, 19 (10) 1496-1502;
DOI: https://doi.org/10.20892/j.issn.2095-3941.2022.0394
Original Article
Preoperative ultrasound combined with routine blood tests in predicting the malignant risk of pancreatic cystic neoplasms
Xiuchao Wang, Junjin Wang, Xi Wei, Lihui Zhao, Bo Ni, Zekun Li, Chuntao Gao, Song Gao, Tiansuo Zhao, Jian Wang, Weidong Ma, Xiao Hu and Jihui Hao
Cancer Biology & Medicine October 2022, 19 (10) 1503-1516;
DOI: https://doi.org/10.20892/j.issn.2095-3941.2022.0258
Issue 11
Special issue on Cancer Research Frontiers / Guest Editor: Prof. Michael Baumann, German Cancer Research Center (DKFZ), Heidelberg, Germany
Editorial
Optimizing the cancer research landscape for the benefit of patients and society: A strategic perspective of the German Cancer Research Center (DKFZ) and its partnerships with university medical centers
Michael Baumann
Cancer Biology & Medicine November 2022, 19 (11) 1517-1522;
DOI: https://doi.org/10.20892/j.issn.2095-3941.2022.0586
Perspective
Roles of eIF5A in the immunosurveillance of cellular senescence
Xiangli Jiang and Fabricio Loayza-Puch
Cancer Biology & Medicine November 2022, 19 (11) 1523-1527;
DOI: https://doi.org/10.20892/j.issn.2095-3941.2022.0408
Reviews
Metabolic regulation of immune responses to cancer
Jannis Wißfeld, Anke Werner, Xin Yan, Nora ten Bosch and Guoliang Cui
Cancer Biology & Medicine November 2022, 19 (11) 1528-1542;
DOI: https://doi.org/10.20892/j.issn.2095-3941.2022.0381
Targeting the EGF receptor family in non-small cell lung cancer—increased complexity and future perspectives
Tobias Boch, Jens Köhler, Melanie Janning and Sonja Loges
Cancer Biology & Medicine November 2022, 19 (11) 1543-1564;
DOI: https://doi.org/10.20892/j.issn.2095-3941.2022.0540
Imaging in translational cancer research
Felix T. Kurz and Heinz-Peter Schlemmer
Cancer Biology & Medicine November 2022, 19 (11) 1565-1585;
DOI: https://doi.org/10.20892/j.issn.2095-3941.2022.0677
Original Articles
The power of a healthy lifestyle for cancer prevention: the example of colorectal cancer
Xuechen Chen, Jie Ding, Hengjing Li, Prudence R. Carr, Michael Hoffmeister and Hermann Brenner
Cancer Biology & Medicine November 2022, 19 (11) 1586-1597;
DOI: https://doi.org/10.20892/j.issn.2095-3941.2022.0397
ENO1 expression and Erk phosphorylation in PDAC and their effects on tumor cell apoptosis in a hypoxic microenvironment
Huizhi Sun, Jing Mo, Runfen Cheng, Fan Li, Yue Li, Yuhong Guo, Yanlei Li, Yanhui Zhang, Xiaoyu Bai, Yalei Wang, Xueyi Dong, Danfang Zhang and Jihui Hao
Cancer Biology & Medicine November 2022, 19 (11) 1598-1616;
DOI: https://doi.org/10.20892/j.issn.2095-3941.2022.0451
Issue 12
Editorial
Inconsistent radiotherapy effects between primary tumors and axillary lymph nodes
Zhao Bi, Pengfei Qiu, Zhaopeng Zhang and Yongsheng Wang
Cancer Biology & Medicine December 2022, 19 (12) 1617-1621;
DOI: https://doi.org/10.20892/j.issn.2095-3941.2022.0590
Perspective
Early detection of gastric cancer in China: progress and opportunities
Hengmin Xu and Wenqing Li
Cancer Biology & Medicine December 2022, 19 (12) 1622-1628;
DOI: https://doi.org/10.20892/j.issn.2095-3941.2022.0655
Reviews
Heterogeneity of neutrophils in cancer: one size does not fit all
Song Chen, Qingyu Zhang, Lisha Lu, Chunhui Xu, Jiajia Li, Jiali Zha, Fengxia Ma, Hongbo R. Luo and Alan Y. Hsu
Cancer Biology & Medicine December 2022, 19 (12) 1629-1648;
DOI: https://doi.org/10.20892/j.issn.2095-3941.2022.0426
Potential new applications of immunotherapy for neuroendocrine neoplasms: immune landscape, current status and future perspectives
Rilan Bai, Wenqian Li and Jiuwei Cui
Cancer Biology & Medicine December 2022, 19 (12) 1649-1661;
DOI: https://doi.org/10.20892/j.issn.2095-3941.2022.0489
Original Article
MiR-378a-3p acts as a tumor suppressor in gastric cancer via directly targeting RAB31 and inhibiting the Hedgehog pathway proteins GLI1/2
Xinxin Xu, Yang Li, Guoxiao Liu, Kai Li, Peng Chen, Yunhe Gao, Wenquan Liang, Hongqing Xi, Xinxin Wang, Bo Wei, Hongtao Li and Lin Chen
Cancer Biology & Medicine December 2022, 19 (12) 1662-1682;
DOI: https://doi.org/10.20892/j.issn.2095-3941.2022.0337